[18F]Florbetapir Positron Emission Tomography: Identification of Muscle Amyloid in Inclusion Body Myositis and Differentiation From Polymyositis

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2018-214644
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

[18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Diagnosing Polymyositis/Dermatomyositis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Detection of ALECT2 Amyloidosis by Positron Emission Tomography-Computed Tomography Imaging With Florbetapir

British Journal of Haematology
Hematology
2017English

18f-Fluorodeoxyglucose and 18f-Flumazenil Positron Emission Tomography in Patients With Refractory Epilepsy

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

Inclusion Body Myositis

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

Inclusion Body Myositis

English

Inclusion Body Myositis

Practical Neurology
MedicineNeurology
2002English

18f-Fluorodeoxyglucose Positron-Emission Tomography-Computed Tomography to Diagnose Recurrent Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Positron Emission Tomography in Breast Cancer: 18f- FDG and Other Radiopharmaceuticals

European Journal of Hybrid Imaging
2018English

Sporadic Inclusion-Body Myositis and Hereditary Inclusion-Body Myopathies

Archives of Neurology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy